LXRX Financial Facts

Interest expense: -1.65M
Collaborative research: 27.69M
See Full Income Statement

Accounts receivable, net of allowances of $35: 738K
Total equity: 185.18M
See Full Balance Sheet

Lexicon Pharmaceuticals, Inc. (LXRX) Earnings

  |   Expand Research on LXRX
Next EPS Date 3/14/24 EPS Growth Rate N/A
Average EPS % Beat Rate -12.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -8.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/14/24 Q423 N/A-$0.21 N/A N/A$5.04M N/A N/A N/A
11/2/23 Q323 N/A-$0.21 N/A N/A$2.06M N/A N/A N/A
11/8/23 Q323 -$0.21-$0.21 $0.00$160K$2.06M N/A Details
8/3/23 Q223 -$0.22-$0.18 -$0.04$320K$133.33K N/A Details
5/4/23 Q123 N/A-$0.19 N/A N/A$50K N/A N/A N/A
3/1/23 Q422 N/A-$0.13 N/A N/A$50K N/A N/A N/A
11/9/22 Q322 -$0.16-$0.14 -$0.02$23K$100K N/A Details
11/9/22 Q322 -$0.16-$0.14 -$0.02$23K$100K N/A Details